- Home
- Publications
- Publication Search
- Publication Details
Title
Tim-3 and its role in regulating anti-tumor immunity
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume 276, Issue 1, Pages 97-111
Publisher
Wiley
Online
2017-03-04
DOI
10.1111/imr.12520
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection
- (2016) Pushpa Jayaraman et al. PLoS Pathogens
- Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression
- (2015) Alberto Sada Japp et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tim-3 promotes intestinal homeostasis in DSS colitis by inhibiting M1 polarization of macrophages
- (2015) Xingwei Jiang et al. CLINICAL IMMUNOLOGY
- Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages
- (2015) Wenjiang Yan et al. GUT
- The Clinical Significance of Abnormal Tim-3 Expression on NK Cells from Patients with Gastric Cancer
- (2015) Zhenxin Wang et al. IMMUNOLOGICAL INVESTIGATIONS
- Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma
- (2015) Liyun Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The immune receptor Tim-3 mediates activation of PI3 kinase/mTOR and HIF-1 pathways in human myeloid leukaemia cells
- (2015) Alexandr Prokhorov et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- TIGIT predominantly regulates the immune response via regulatory T cells
- (2015) Sema Kurtulus et al. JOURNAL OF CLINICAL INVESTIGATION
- T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival
- (2015) Meng Yang et al. JOURNAL OF SURGICAL ONCOLOGY
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8+ T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression
- (2015) Meimei Bu et al. TUMOR BIOLOGY
- PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy
- (2015) S-C Wang et al. Cell Death & Disease
- An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction
- (2015) Chen Zhu et al. Nature Communications
- Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients
- (2015) Isabel Sada-Ovalle et al. Journal of the International AIDS Society
- Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
- (2015) Chiao-Wen Kang et al. Scientific Reports
- The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas
- (2015) Y. Komohara et al. Cancer Immunology Research
- Interferon-β Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells
- (2015) Nicolas Boivin et al. PLoS One
- Expression of TIM-3 on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid of rheumatoid arthritis
- (2014) Shufeng Li et al. APMIS
- Enhanced suppressor function of TIM-3+FoxP3+regulatory T cells
- (2014) Anne-Sophie Gautron et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis
- (2014) Marina Saresella et al. FASEB JOURNAL
- Lack of TIM-3 Immunoregulation in Multiple Sclerosis
- (2014) L. Yang et al. JOURNAL OF IMMUNOLOGY
- Immunoregulation of Dendritic Cells by the Receptor T cell Ig and Mucin Protein-3 via Bruton’s Tyrosine Kinase and c-Src
- (2014) Neeraj Maurya et al. JOURNAL OF IMMUNOLOGY
- Tim-3 Directly Enhances CD8 T Cell Responses to Acute Listeria monocytogenes Infection
- (2014) J. V. Gorman et al. JOURNAL OF IMMUNOLOGY
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy
- (2014) Bronwen R. Burton et al. Nature Communications
- Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
- (2014) I. P. da Silva et al. Cancer Immunology Research
- Prognostic Value of T Cell Immunoglobulin Mucin-3 in Prostate Cancer
- (2013) Yong-Rui Piao et al. Asian Pacific Journal of Cancer Prevention
- A Novel Soluble Form of Tim-3 Associated with Severe Graft-versus-Host Disease
- (2013) John A. Hansen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
- (2013) H-B Jie et al. BRITISH JOURNAL OF CANCER
- Liver-primed CD8+T cells suppress antiviral adaptive immunity through galectin-9-independent T-Cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice
- (2013) Joseph S. Dolina et al. HEPATOLOGY
- A Disintegrin and Metalloprotease (ADAM) 10 and ADAM17 Are Major Sheddases of T Cell Immunoglobulin and Mucin Domain 3 (Tim-3)
- (2013) Katja Möller-Hackbarth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- T Cell Ig and Mucin Domain-Containing Protein 3 Is Recruited to the Immune Synapse, Disrupts Stable Synapse Formation, and Associates with Receptor Phosphatases
- (2013) K. L. Clayton et al. JOURNAL OF IMMUNOLOGY
- Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer
- (2013) Zhiqiang Guo et al. Journal of Translational Medicine
- Differential Regulation of Interleukin-12 (IL-12)/IL-23 by Tim-3 Drives TH17 Cell Development during Hepatitis C Virus Infection
- (2013) J. M. Wang et al. JOURNAL OF VIROLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
- (2013) Yang Cao et al. PLoS One
- Tim-3 Expression Defines Regulatory T Cells in Human Tumors
- (2013) Jing Yan et al. PLoS One
- Cis Association of Galectin-9 with Tim-3 Differentially Regulates IL-12/IL-23 Expressions in Monocytes via TLR Signaling
- (2013) Cheng J. Ma et al. PLoS One
- Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
- (2013) Jing Jiang et al. PLoS One
- T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer
- (2013) Jianwen Bai et al. TUMOR BIOLOGY
- Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: Role in hepatitis B vaccine failure during hepatitis C infection
- (2013) Jia M. Wang et al. VACCINE
- HMGB1: The Central Cytokine for All Lymphoid Cells
- (2013) Guanqiao Li et al. Frontiers in Immunology
- TIM3+FOXP3+regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
- (2013) Kaori Sakuishi et al. OncoImmunology
- Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells
- (2012) R. G. Veenstra et al. BLOOD
- Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
- (2012) L. C. Ndhlovu et al. BLOOD
- Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
- (2012) M. K. Gleason et al. BLOOD
- Blockade of Tim-3 signaling restores the virus-specific CD8+T-cell response in patients with chronic hepatitis B
- (2012) Wei Wu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- Down-regulation of interleukin-2 production by CD4+ T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription
- (2012) Mi Jin Lee et al. IMMUNOBIOLOGY
- Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs
- (2012) Shipra Gupta et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma
- (2012) Zhi-Zhang Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Antigen-Independent Induction of Tim-3 Expression on Human T Cells by the Common -Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Is Associated with Proliferation and Is Dependent on the Phosphoinositide 3-Kinase Pathway
- (2012) S. Mujib et al. JOURNAL OF IMMUNOLOGY
- T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer
- (2012) Danian Tong et al. MOLECULAR BIOLOGY REPORTS
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion
- (2012) Manu Rangachari et al. NATURE MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
- (2012) Xin Gao et al. PLoS One
- Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
- (2012) Gaia Nebbia et al. PLoS One
- Tim-3-Expressing CD4+ and CD8+ T Cells in Human Tuberculosis (TB) Exhibit Polarized Effector Memory Phenotypes and Stronger Anti-TB Effector Functions
- (2012) Yueqin Qiu et al. PLoS Pathogens
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
- (2011) Marc Pellegrini et al. CELL
- Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes
- (2011) Motoko Kanzaki et al. ENDOCRINOLOGY
- Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes
- (2011) Ying Zhang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
- (2011) J. Lee et al. MOLECULAR AND CELLULAR BIOLOGY
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Tim-3 Negatively Regulates IL-12 Expression by Monocytes in HCV Infection
- (2011) Ying Zhang et al. PLoS One
- Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
- (2011) M. Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease
- (2011) Kenichi Morimoto et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection
- (2011) Wei Wu et al. Virology Journal
- Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer
- (2010) Bangwei Cao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
- (2010) Yoshikane Kikushige et al. Cell Stem Cell
- Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity
- (2010) Ying Liu et al. CLINICAL IMMUNOLOGY
- T-bet, a Th1 transcription factor regulates the expression of Tim-3
- (2010) Ana C. Anderson et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
- (2010) Xiaoyuan Huang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tim3 binding to galectin-9 stimulates antimicrobial immunity
- (2010) Pushpa Jayaraman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Premature Terminal Exhaustion of Friend Virus-Specific Effector CD8+ T Cells by Rapid Induction of Multiple Inhibitory Receptors
- (2010) S. Takamura et al. JOURNAL OF IMMUNOLOGY
- Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells
- (2010) V. Dardalhon et al. JOURNAL OF IMMUNOLOGY
- T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells
- (2010) Rosemarie H. DeKruyff et al. JOURNAL OF IMMUNOLOGY
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
- (2010) H.-T. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
- (2009) M. Nakayama et al. BLOOD
- Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression
- (2009) S. Mumprecht et al. BLOOD
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells
- (2009) L. Golden-Mason et al. JOURNAL OF VIROLOGY
- A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection
- (2009) J. S. Yi et al. SCIENCE
- PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
- (2008) R. Yamamoto et al. BLOOD
- Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells
- (2008) Feng Wang et al. IMMUNOBIOLOGY
- Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
- (2008) R. Brad Jones et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started